Myriad Genetics Data Breach Lawsuit Investigation - Claim Depot
Shamis & Gentile P.A. is investigating a data breach at Myriad Genetics, Inc., which detected unauthorized access to its IT network on November 2, 2026.
Founded in 1991, Myriad Genetics focuses on genetic testing and precision medicine, offering molecular diagnostic tests that help assess disease risk and guide treatment decisions. The company has suspended some testing operations and engaged external experts to investigate the breach and determine the full scope of the unauthorized access.
Breach Response
After discovering the incident, Myriad Genetics initiated incident response procedures, including alerting government systems and notifying certain customers. The company reported the incident to the U.S. Securities and Exchange Commission and stated that most of its systems remained operational.
Legal Action
If you were affected by the data breach, your sensitive personally identifiable information may have been exposed, and you may be eligible for compensation.
If you were affected by the Myriad Genetics data breach, your sensitive personally identifiable information may have been exposed, and you may be eligible for compensation. Lawyers are actively investigating claims related to this incident.
Related
